Stocks to Buy. In this article, we are going to take a look at where Boston Scientific Corporation (NYSE:BSX) stands against ...
What’s Causing Boston Scientific Corporation (BSX) Stock’s 16.53% Jump Over the Last Six Months?
On Friday, Boston Scientific Corporation (BSX) stock saw a decline, ending the day at $86.99 which represents a decrease of $-0.60 or -0.69% from the prior close of $87.59. The stock opened at $87.12 ...
Boston Scientific Corp. last week announced that it has closed on its acquisition of Irvine-based medical device maker ...
1d
Mizuho Securities analyst Anthony Petrone has maintained their bullish stance on BSX stock, giving a Buy rating yesterday.Don't Miss our Black ...
Boston Scientific (BSX – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Larry ...
On Thursday, Boston Scientific Corporation (BSX) stock saw a decline, ending the day at $87.59 which represents a decrease of $-1.18 or -1.33% from the prior close of $88.77. The stock opened at ...
Abbott’s Amulet IDE trial put its left atrial appendage closure device up against the Watchman 2.5, which was approved by the ...
Marlborough, Massachusetts Tuesday, November 19, 2024, 17:00 Hrs [IST] ...
AVVIGO is an intravascular ultrasound (IVUS) and fractional flow reserve (FFR) system designed to provide high-quality IVUS ...
We recently compiled a list of the 10 Best Low Volatility Stocks to Invest in Now. In this article, we are going to take a ...
Boston Scientific announced positive three-year primary endpoint results from a clinical trial of its Watchman FLX device.
Shares of Boston Scientific Corp. BSX shed 0.69% to $86.99 Friday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index SPX falling 1.32% to 5,870 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback